Engineered immune cells take on Hard-to-Treat cancers
Disease control
ENROLLING_BY_INVITATION
This study tests a new treatment called IMC001 for people with advanced epithelial solid tumors (cancers that start in the lining of organs). IMC001 is made from a patient's own immune cells, which are modified in a lab to better recognize and attack cancer cells. The trial has t…
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Immunofoco Biotechnology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC